用黄及其类型预防阿尔茨海默病
George Uhl1, Balaji Kannan2, Joungil Choi3
1Department of Neurology, University of Maryland School of Medicine, Baltimore MD 21201, USA; Neurology and Research Services, VA Maryland Healthcare System, Baltimore MD 21201, USA; Department of Pharmacology, University of Maryland School of Medicine, Baltimore MD 21201, USA.
The journal of prevention of Alzheimer's disease
|September 4, 2025
概括
饮食中摄入较多的黄与阿尔茨海默病 (AD) 和痴呆症的风险显著降低有关. 这种保护作用在具有更高AD遗传倾向的个体中尤为明显.
科学领域:
- 营养神经科学
- 老年学
- 药理学
背景情况:
- 阿尔茨海默病 (AD) 在老年人群中构成重大健康挑战.
- 人们越来越认识到饮食因素在预防神经退行性疾病中的作用.
- 一类植物性化合物 - - 黄醇已显示出潜在的神经保护性.
研究的目的:
- 调查饮食中的黄与阿尔茨海默病 (AD) 和痴呆症的发病率之间的联系.
- 探索AD风险中的潜在基因环境相互作用.
- 确定弗拉醇神经保护作用的机制.
主要方法:
- 分析了四项观察性研究的数据,研究了饮食中的黄摄入量和AD/痴呆症诊断.
- 评估黄的剂量反应关系和结构活性模式.
- 从动物模型和体外研究中对黄机制的证据的审查.
主要成果:
- 饮食中较高的黄醇 (或它们的糖化物) 与阿尔茨海默病/痴呆症诊断的发生率降低有关.
- 在基因高风险的人群中观察到AD风险的大幅降低 (近50%),这表明基因与环境的相互作用.
- 益处与适度到中度的消费水平和特定的黄醇结构有关.
结论:
- 通过饮食摄入黄是一种有前途的可修改策略,可减少老年人群的阿尔茨海默病发病率.
- 这些发现强调了在抗阿尔茨海默病预防中考虑遗传倾向和饮食模式的重要性.
- 为了缓解AD,需要进一步研究黄类药物和补充剂的策略.
相关概念视频
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33


